pharmaphorum

SEPTEMBER 30, 2020

The signatories of a new Biotech Social Pact with Europe and patients explain why healthcare calls for a new social contract, not a pharmaceutical strategy. As Europe continues its efforts to battle the Covid-19 pandemic, it is rightfully focusing its attention on the longer-term implications of this crisis. One common thread is clearly emerging from EU and national discussions: to reinforce Europe’s “strategic autonomy” and “technological sovereignty” in key industrial sectors.

141

141

Outsourcing Pharma

SEPTEMBER 28, 2020

Ena Respiratoryâs preventative nasal spray treatment could reach human trials within four months, following results from an animal study released today which showed the spray reduced COVID-19 replication by up to 96%.

133

133

Druggist

SEPTEMBER 30, 2020

Buscopan and mebeverine are two common drugs used for symptomatic treatment of irritable bowel syndrome (IBS). Both drugs can be prescribed by a doctor or purchased over the counter from pharmacies and in case of Bucopa IBS relief from supermarkets. Buscopan vs Mebeverine lists similarities and differences between both drugs. I will review their role in the management of IBS in accordance with the treatment guidelines on irritable bowel syndrome.

98

98

Pharma Tutor

OCTOBER 2, 2020

About Author. Nrusingha Panda. Department of Quality Assurance, Mankind Pharma Ltd., Bermiok Elaka, South Sikkim, Sikkim, Zip Code- 737126, India. ABSTRACT. Regulatory authorities expect from pharmaceutical industries that there should be written and approved procedures of sampling to collect samples for testing before approval of components of drug products, container and closure of drug products and drug product itself to assure patient safety in all respects whether chemical, physical and bio

Dosage 93

Dosage Packaging 93

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

SEPTEMBER 28, 2020

The FDA has launched its Digital Health Center of Excellence (DHCoE), as the agency continues with its commitment to advancing use of technology such as mobile health devices, software and wearables to create medical products. Housed within the agency’s Center for Devices and Radiological Health, the DHCoE is part of a wider strategy to encourage development of digital health products and therapeutics.

FDA 140

FDA 140

Outsourcing Pharma

SEPTEMBER 30, 2020

The companyâs Phase II trial of ultramicronized PEA has received FDA approval and expects to begin dosing patientparticipants as early as next month.

FDA 118

FDA 118

indispensable health

SEPTEMBER 29, 2020

An Interview With Rogers Elebra, PharmD. Recorded August 28, 2020. What Is Your Name And Job Title? My name is Rogers Elebra and I am currently the pharmacy director at Surgeons Choice Medical Center in Southfield, Michigan, and also a team member of Indispensable Health. What Is Your Role With Indispensable Health? I am part of the Pharmacy Management team.

Hospitals 52

Hospitals Communication Patient Care 52

pharmaphorum

SEPTEMBER 30, 2020

Regeneron’s antibody cocktail seems to reduce levels of coronavirus and improve symptoms in patients, according to early test results. This first data comes from a descriptive analysis from the seamless phase 1/2/3 trial that Regeneron hopes will hurry the medicine dubbed REGN-COV2 to market. The ongoing double-blind trial measures the effect of adding REGN-COV2 to usual standard of care, compared with usual standard of care.

Immunization 135

Immunization 135

Outsourcing Pharma

SEPTEMBER 28, 2020

Results from the research indicate use of ACE in inhibitors and ARBs could prove useful in treating COVID-19 patients of African-American descent.

76

76

Pharma Mirror

OCTOBER 1, 2020

Since the in-person PACK EXPO International and Healthcare Packaging EXPO have been cancelled, the process and packaging technology specialist Syntegon is presenting its latest solutions at the virtually-hosted PACK EXPO Connects from November 9 to 13, 2020. In a series of video and Q&A sessions, Syntegon is showcasing its intelligent and sustainable technologies for the.

Packaging 52

Packaging 52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharma Marketing Network

SEPTEMBER 28, 2020

Six months after the Covid -19 pandemic upended health, personal, and economic life for millions around the world, the importance of good, even great leadership in business settings has taken on new dimensions. The world of pharma—and every other business imaginable—initially experienced shock, confusion, and no small amount of anxiety. After all, the novel, easily spread, and deadly virus decimated lives and businesses were shuttered.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

SEPTEMBER 29, 2020

The pharmaceutical industry is one of the most scientifically innovative and competitive industries, particularly in oncology. As of 2018, there were over 1,100 cancer therapies in development, and as of 2020, 362 of them were cell and gene therapies. As a result, there is a need for continued innovation and increased efficiency in terms of drug development to manage cost, complexity and speed to provide potentially transformative therapies for cancer patients.

Chemotherapy 122

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 122

Outsourcing Pharma

SEPTEMBER 29, 2020

The companyâs studies exploring the use of opaganib in severe COVID-19 patients have been approved in Brazil and other countries around the globe.

74

74

Pharma Mirror

OCTOBER 1, 2020

Ranitidine is a pharmaceutical drug that is categorized as a histamine antagonist, also called an H2 blocker, that has popularly been used to treat acid reflux. However, this medication had recently raised controversies when the Food and Drug Administration (FDA) announced a product recall of this drug from the market due to the presence of. The post 6 Reasons Why Ranitidine Is Harmful and How It Caused Cancer to Many appeared first on Pharma Mirror Magazine.

FDA 52

FDA 52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharma Marketing Network

SEPTEMBER 28, 2020

Six months after the Covid -19 pandemic upended health, personal, and economic life for millions around the world, the importance of good, even great leadership in business settings has taken on new dimensions. The world of pharma—and every other business imaginable—initially experienced shock, confusion, and no small amount of anxiety. After all, the novel, easily spread, and deadly virus decimated lives and businesses were shuttered.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

OCTOBER 1, 2020

For a long time, venture capital (VC) firms have been controlled mainly by men. But things are changing and women are becoming more influential in life sciences VCs, with an increase in business going to all-female teams. We spoke with two female VC leaders about how women could act as agents for change in this male-dominated world. Last year saw a record amount of venture capital – $17.2 billion – raised by women, according to the financial information company Pitchbook.

121

121

Outsourcing Pharma

SEPTEMBER 29, 2020

The companyâs studies exploring the use of opaganib in severe COVID-19 patients have been approved in Brazil and other countries around the globe.

64

64

Pharma Mirror

OCTOBER 1, 2020

Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces that it has received a EUR 1.2 million grant from VLAIO, the Flanders organization for Innovation & Entrepreneurship, for the development of the highly innovative GeneFusion Assay on its easy, rapid molecular and fully automated diagnostics platform Idylla™.

52

52

Med Ed 101

SEPTEMBER 30, 2020

In this case scenario, I explore some of the possible reasons that you may see a patient on duplicate SSRIs. A 68 year old female has a history of depression, breast cancer, diabetes, hypertension, and mild osteoarthritis. Current medications include: Fluoxetine 20 mg daily Dapagliflozin 10 mg daily Lantus 15 units at night Tamoxifen 20 […]. The post Reasons For Duplicate SSRIs appeared first on Med Ed 101.

40

40

pharmaphorum

SEPTEMBER 28, 2020

Shares in UK biotech Valirx were up sharpy this morning after its lead drug VAL201 showed evidence of efficacy in advanced prostate cancer in its first clinical trial. The company reported results from 11 patents taking part in the phase 1/2 study which showed a 54.5% overall response rate with VAL201, with a promising safety and tolerability profile.

Hospitals 120

Hospitals 120

Outsourcing Pharma

OCTOBER 1, 2020

The survey, unveiled ahead of next week's CPhI Festival of Pharma, reveals perspectives, concerns and future plans of more than 500 industry executives.

54

54

Pharma Tutor

OCTOBER 1, 2020

82

82

Med Ed 101

SEPTEMBER 27, 2020

In this scenario, I review how medications can increase the blood clot risk. A 66 year old female is taking the following medications. Aspirin 81 mg daily Lamotrigine 100 mg BID Apixaban 5 mg BID Acetaminophen 500 mg BID Pantoprazole 40 mg daily Baclofen 10 mg BID Metoprolol 25 mg BID Conjugated estrogens 0.625 mg […]. The post Medication List Review – Blood Clot Risk appeared first on Med Ed 101.

40

40

pharmaphorum

OCTOBER 1, 2020

A digital tool that allows doctors to monitor patients with COVID-19 remotely in real time and intervene when treatment is needed has been launched in the UK. The mobile app – developed by digital heath specialist Careology – provides advice on COVID-19 symptoms and links patients with doctors at the London General Practice, a private GP group with around 50,000 people on its books, via online video consultations.

117

117

Outsourcing Pharma

SEPTEMBER 30, 2020

The pharma ingredients provider discusses new products, supply-chain obstacles, and what the future of the industry might hold, ahead of the online event.

52

52

Pharma Times

SEPTEMBER 28, 2020

Insights from project could potentially improve precision medicine use for paediatric AML

50

50

Druggist

SEPTEMBER 27, 2020

Ibuprofen is one of the most popular drugs purchased over the counter and one of the essential medicines for the management of pain and inflammation. Over the counter ibuprofen comes in different strengths, forms, and several brands , some of which do not differ from one another with the amount of ibuprofen present. In today’s post, I will review the different forms and brands of ibuprofen.

Labelling 59

Labelling 59

pharmaphorum

OCTOBER 2, 2020

Psychedelic therapy company Field Trip Psychedelics has announced that it will soon join the growing list of psychedelic companies going public. . Through a direct listing on the CSE, the company expects trading to begin on 7 October after entering into an amalgamation agreement in August with Newton Energy Corp. Field Trip aims to “take a personalised approach to mental wellness” by blending legal psychedelic-enhanced therapy, mindfulness, and self-care with a series of sessions with trained ps

Compounding 117

Compounding FDA 117

Outsourcing Pharma

SEPTEMBER 29, 2020

TeleConsent empowers trial teams to obtain informed consent and re-consent from patients participating in clinical studies, within a fully remote system.

52

52

Pharma Times

SEPTEMBER 28, 2020

Treatment is indicated for use in adults with moderate-to-severe active rheumatoid arthritis

49

49

pharmaphorum

SEPTEMBER 29, 2020

UK Prime Minister Boris Johnson has told the UN General Assembly that the UK will donate £571 million ($735 million) to the COVAX scheme aimed at distributing COVID-19 vaccines fairly around the world. The lion’s share of that total – around £500 million – will be “for developing countries to protect themselves,” said the PM in a recorded speech given to the assembly, delivered just before the number of deaths due to coronavirus topped 1 million worldwide.

Vaccines 116

Vaccines 116

pharmaphorum

OCTOBER 2, 2020

New research shows that the COVID-19 pandemic is encouraging people to take their health into their own hands, and experts say this trend towards self-care could be a significant boon for healthcare systems – one the pharma industry should be encouraging. We often hear how early detection and disease prevention will be key for the future of healthcare – alleviating pressure on already over-stressed health systems by nipping costly and preventable diseases in the bud before they can drain healthc

Communication 111

Communication 111

pharmaphorum

OCTOBER 1, 2020

Many companies in the life sciences industry are slow to adopt new technologies. This is down to greater costs, greater operational burden, and uncertainty with meeting the complex regulatory requirements put in place. However, there has been a lot of advancement in new and emerging technologies in recent years. The FDA has recognized their benefits and is increasingly supportive of their use.

FDA 110

FDA 110

pharmaphorum

SEPTEMBER 29, 2020

The FDA has fast tracked development of AbbVie’s potential spinal injury drug, elezanumab, a process that will be aided by digital analysis. The regulator has also granted it orphan status, which cuts development costs and potentially boosts profits if approved. Elezanumab is a monoclonal antibody that binds selectively to repulsive guidance molecule, which is known to inhibit regeneration of neurons and functional recovery following central nervous system damage.

FDA 105

FDA 105